Suzhou, China

Jian Han

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Shanghai Ark Biopharmaceutical Co., Ltd., Suzhou Ark Biopharmaceutical Co., Ltd.. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jian Han. Retrieved from https://idiyas.com/inventor/jian-han-ra9vx1p8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2020-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Jian Han: Pioneering Solutions for Hepatitis B

Introduction: Jian Han, an accomplished inventor based in Suzhou, China, is making significant strides in the field of biopharmaceuticals with his innovative research. His work focuses on developing compounds aimed at addressing critical health issues, such as hepatitis B virus infections.

Latest Patents: Jian Han holds one patent for a novel dihydroisoquinoline compound. This compound, characterized by its general formula I, demonstrates potential effectiveness in preventing or treating hepatitis B virus infections, showcasing the importance of his contributions to medical science.

Career Highlights: Currently, Jian Han is employed at Suzhou Ark Biopharmaceutical Co., Ltd., where he applies his expertise to advance therapeutic solutions in the biopharmaceutical sector. His dedication to research and development in this area has positioned him as a significant contributor to the fight against viral infections.

Collaborations: Throughout his career, Jian has worked alongside talented colleagues, including Cheng Peng and Qing Xu. Their teamwork and collaborative efforts further enhance the innovative projects underway at Suzhou Ark Biopharmaceutical Co., Ltd.

Conclusion: Jian Han stands out as a determined inventor dedicated to creating impactful solutions for medicine. His patent for the dihydroisoquinoline compound signifies a crucial step forward in the battle against hepatitis B, highlighting the essential role of inventors in advancing public health. As he continues his work at Suzhou Ark Biopharmaceutical Co., Ltd., the future looks promising for both Jian and the field of biopharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…